help me understand oral GLP-1, I have read the wiki twice
Slightly embarrassed to be asking this, but: help me understand oral GLP-1, I have read the wiki twice. Holding off on any opinion until phase 3 reports. That is not a satisfying position and it is the honest one. The analytical point, which this board keeps getting wrong by importing habits from the peptide side.…
It is a non-peptide small-molecule agonist at the GLP-1 receptor. That is a substantial medicinal chemistry achievement: getting a small molecule to activate a receptor evolved for a peptide ligand.
Same view. The analytical problem is different enough that the usual purity discussions here do not transfer cleanly.
no food and water restrictions is the practical difference people care about
Retitled to name the programme. It is what makes these threads findable in a year.
the boards keep comparing it to injectables at matched doses, which is meaningless
Compared milligram figures across two completely different molecule classes in a comment. Deserved the correction.
Agreed — non-peptide is the fact that everything else follows from, including the manufacturing and the analytics.